Kidney Disease: Improving Global Outcomes (KDIGO)

An expert describes his perspective on sequencing, APRIL inhibition, proteinuria endpoints, and long-term kidney preservation in IgA nephropathy.

On IgAN Awareness Day, clinicians highlight earlier diagnosis, dynamic risk stratification, and emerging targeted therapies reshaping care.

Catch up on nephrology headlines you missed from Q1 2026.

KDIGO Launches Focused Update to 2024 CKD Guideline on Emerging Therapies

2025 KDIGO guidelines reshape IgA nephropathy care with earlier biopsy, tighter proteinuria targets, and personalized treatment strategies.

The updated guideline offers recommendations for RBC transfusions and iron management, while continuing to prioritize patient-centered care.

The new guideline provides healthcare providers, people living with ADPKD, and stakeholders with practical tools to improve diagnosis, care, and treatment.

The report acknowledges the global health challenge of CKD-MBD, and its effect on both skeletal and cardiovascular systems in people with CKD.